{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:30:49Z","timestamp":1782937849358,"version":"3.54.5"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Several genetic polymorphisms of the innate immune system have been described to increase the risk of cytomegalovirus (CMV) infection in transplant patients. The aim of this study was to assess the impact of a polygenic score to predict CMV infection and disease in high risk CMV transplant recipients (heart, liver, kidney or pancreas). On hundred and sixteen CMV-seronegative recipients of grafts from CMV-seropositive donors undergoing heart, liver, and kidney or pancreas transplantation from 7 centres were prospectively included for this purpose during a 2-year period. All recipients received 100-day prophylaxis with valganciclovir. CMV infection occurred in 61 patients (53%) at 163 median days from transplant, 33 asymptomatic replication (28%) and 28 CMV disease (24%). Eleven patients (9%) had recurrent CMV infection. Clinically and\/or functionally relevant single nucleotide polymorphisms (SNPs) from<jats:italic>TLR2<\/jats:italic>,<jats:italic>TLR3<\/jats:italic>,<jats:italic>TLR4<\/jats:italic>,<jats:italic>TLR7<\/jats:italic>,<jats:italic>TLR9<\/jats:italic>,<jats:italic>AIM2<\/jats:italic>,<jats:italic>MBL2<\/jats:italic>,<jats:italic>IL28<\/jats:italic>, IFI16,<jats:italic>MYD88<\/jats:italic>,<jats:italic>IRAK2<\/jats:italic>and<jats:italic>IRAK4<\/jats:italic>were assessed by real time polymerase chain reaction (RT-PCR) or sequence-based typing (PCR-SBT). A polygenic score including the<jats:italic>TLR4<\/jats:italic>(rs4986790\/rs4986791),<jats:italic>TLR9<\/jats:italic>(rs3775291),<jats:italic>TLR3<\/jats:italic>(rs3775296),<jats:italic>AIM2<\/jats:italic>(rs855873),<jats:italic>TLR7<\/jats:italic>(rs179008),<jats:italic>MBL<\/jats:italic>(OO\/OA\/XAO),<jats:italic>IFNL3\/IL28B<\/jats:italic>(rs12979860) and<jats:italic>IFI16<\/jats:italic>(rs6940) SNPs was built based on the risk of CMV infection and disease. The CMV score predicted the risk of CMV disease with an AUC of the model of 0.68, with sensitivity and specificity of 64.3 and 71.6%, respectively. Even though further studies are needed to validate this score, its use would represent an effective model to develop more robust scores predicting the risk of CMV disease in donor\/recipient mismatch (D+\/R-) transplant recipients.<\/jats:p>","DOI":"10.3389\/fimmu.2022.897912","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T16:21:23Z","timestamp":1660062083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+\/R- Transplant Recipients. A Prospective Multicenter Cohort Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Marta","family":"Bodro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Sanclemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Casad\u00f3-Llombart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Fern\u00e1ndez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cantisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Montejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Oriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Angeles","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GESITRA-IC\/SEIMC\/REIPI investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra064928","article-title":"Infection in Solid-Organ Transplant Recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral Medications to Prevent Cytomegalovirus Disease and Early Death in Recipients of Solid-Organ Transplants: A Systematic Review of Randomised Controlled Trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12848","article-title":"Effect of Mammalian Target of Rapamycin Inhibitors on Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Polyclonal Antilymphocyte Globulins: A Propensity Score-Matching Analysis","volume":"29","author":"Cervera","year":"2016","journal-title":"Transpl Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000746","article-title":"Update on Cytomegalovirus in Transplant Recipients: New Agents, Prophylaxis, and Cell-Mediated Immunity","volume":"34","author":"Manuel","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1008453","article-title":"Innate Immunity in Solid Organ Transplantation: An Update and Therapeutic Opportunities","volume":"11","author":"B\u00e9land","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate Immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.08.012","article-title":"Innate Recognition of Viruses","volume":"27","author":"Pichlmair","year":"2007","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate Immunity to Virus Infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00616","article-title":"Host Genetics of Cytomegalovirus (CMV) Pathogenesis","volume":"10","author":"Sezgin","year":"2019","journal-title":"Front Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15160","article-title":"Impact of MBL2 Gene Polymorphisms on the Risk of Infection in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis","volume":"19","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"Am J Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13107","article-title":"Association Between Individual and Combined SNPs in Genes Related to Innate Immunity and Incidence of CMV Infection in Seropositive Kidney Transplant Recipients","volume":"15","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Am J Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1086\/514339","article-title":"Relationship Between Toll-Like Receptor 2 Polymorphism and Cytomegalovirus Disease After Liver Transplantation","volume":"44","author":"Kijpittayarit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31816c7dc7","article-title":"Association Between a Polymorphism in the IL-12p40 Gene and Cytomegalovirus Reactivation After Kidney Transplantation","volume":"85","author":"Hoffmann","year":"2008","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01902.x","article-title":"Investigation of Promoter Variations in Dendritic Cell-Specific ICAM3-Grabbing Non-Integrin (DC-SIGN) (CD209) and Their Relevance for Human Cytomegalovirus Reactivation and Disease After Allogeneic Stem-Cell Transplantation","volume":"14","author":"Mezger","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2009.06.004","article-title":"Polymorphisms in Toll-Like Receptor Genes and Susceptibility to Infections in Allogeneic Stem Cell Transplantation","volume":"37","author":"Carvalho","year":"2009","journal-title":"Exp Hematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1086\/644501","article-title":"The R753Q Polymorphism Abrogates Toll-Like Receptor 2 Signaling in Response to Human Cytomegalovirus","volume":"49","author":"Brown","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.06.056","article-title":"Influence of Mannose-Binding Lectin Gene Polymorphisms on the Invasiveness of Cytomegalovirus Disease After Solid Organ Transplantation","volume":"41","author":"Cervera","year":"2009","journal-title":"Transplant Proc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.068841","article-title":"Association Between a Polymorphism in the Human Programmed Death-1 (PD-1) Gene and Cytomegalovirus Infection After Kidney Transplantation","volume":"47","author":"Hoffmann","year":"2010","journal-title":"J Med Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.039","article-title":"Mannose-Binding Lectin and Ficolin-2 Gene Polymorphisms Predispose to Cytomegalovirus (Re)Infection After Orthotopic Liver Transplantation","volume":"55","author":"De Rooij","year":"2011","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.11.008","article-title":"A Polymorphism Linked to Elevated Levels of Interferon-\u03b3 Is Associated With an Increased Risk of Cytomegalovirus Disease Among Caucasian Lung Transplant Recipients at a Single Center","volume":"30","author":"Mitsani","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir819","article-title":"Homozygosity for the Toll-Like Receptor 2 R753Q Single-Nucleotide Polymorphism Is a Risk Factor for Cytomegalovirus Disease After Liver Transplantation","volume":"205","author":"Kang","year":"2012","journal-title":"J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu144","article-title":"Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus","volume":"210","author":"Egli","year":"2014","journal-title":"J Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.5.1847-1850.2006","article-title":"Polymorphisms in the Genes Encoding Chemokine Receptor 5, Interleukin-10, and Monocyte Chemoattractant Protein 1 Contribute to Cytomegalovirus Reactivation and Disease After Allogeneic Stem Cell Transplantation","volume":"44","author":"Loeffler","year":"2006","journal-title":"J Clin Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169420","article-title":"Association of TLR3 L412F Polymorphism With Cytomegalovirus Infection in Children","volume":"12","author":"Studzi\u00f1ska","year":"2017","journal-title":"PLos One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154100","article-title":"TLR9 -1486t\/C and 2848C\/T SNPs Are Associated With Human Cytomegalovirus Infection in Infants","volume":"11","author":"Paradowska","year":"2016","journal-title":"PLos One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122831","article-title":"TLR9 2848 GA Heterozygotic Status Possibly Predisposes Fetuses and Newborns to Congenital Infection with Human Cytomegalovirus","author":"Wujcicka","year":"2015","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.8.4320","article-title":"Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses","volume":"171","author":"Lor\u00e9","year":"2003","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00354.x","article-title":"Relevance of Toll-Like Receptor-4 Polymorphisms in Renal Transplantation","volume":"67","author":"Ducloux","year":"2005","journal-title":"Kidney Int"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000264999.71318.2b","article-title":"The Influence of Innate Immunity Gene Receptors Polymorphisms in Renal Transplant Infections","volume":"83","author":"Cervera","year":"2007","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.5799","article-title":"Cutting Edge: Overlapping Functions of TLR7 and TLR9 for Innate Defense Against a Herpesvirus Infection","volume":"180","author":"Zucchini","year":"2008","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01219-18","article-title":"Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells","volume":"92","author":"Dominguez-Molina","year":"2018","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2016.10.003","article-title":"Clinical Significance of the Single Nucleotide Polymorphism TLR2 R753Q in Heart Transplant Recipients at Risk for Cytomegalovirus Disease","volume":"84","author":"Schneider","year":"2016","journal-title":"J Clin Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23865","article-title":"Effect of the IL28B Rs12979860 C\/T Polymorphism on the Incidence and Features of Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Patients","volume":"86","author":"Bravo","year":"2014","journal-title":"J Med Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.9.6176","article-title":"IFN-\u03b1\u03b2-Mediated Inflammatory Responses and Antiviral Defense in Liver Is TLR9-Independent But MyD88-Dependent During Murine Cytomegalovirus Infection","volume":"179","author":"Hokeness-Antonelli","year":"2007","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2010.12.005","article-title":"What the Myddosome Structure Tells Us About the Initiation of Innate Immunity","volume":"32","author":"Gay","year":"2011","journal-title":"Trends Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28105","article-title":"A Frequent Hypofunctional IRAK2 Variant Is Associated With Reduced Spontaneous Hepatitis C Virus Clearance","volume":"62","author":"Wang","year":"2015","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000251721.90688.c2","article-title":"Association Between Mannose-Binding Lectin Deficiency and Cytomegalovirus Infection After Kidney Transplantation","volume":"83","author":"Manuel","year":"2007","journal-title":"Transplantation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545839","article-title":"AIM2 Inflammasome in Infection, Cancer, and Autoimmunity: Role in DNA Sensing, Inflammation, and Innate Immunity","volume":"46","author":"Man","year":"2016","journal-title":"Eur J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002498","article-title":"The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Cytomegalovirus Replication","volume":"88","author":"Gariano","year":"2012","journal-title":"PLos Pathog"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24846","article-title":"Human Cytomegalovirus Triggers the Assembly of AIM2 Inflammasome in THP-1-Derived Macrophages","volume":"89","author":"Huang","year":"2017","journal-title":"J Med Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00384-14","article-title":"Innate Nuclear Sensor IFI16 Translocates Into the Cytoplasm During the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions During the Late Stage","volume":"88","author":"Dell\u2019Oste","year":"2014","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13544","article-title":"Invasive Aspergillosis in Solid-Organ Transplant Recipients: Guidelines From the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Husain","year":"2019","journal-title":"Clin Transplant"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i32.11116","article-title":"Genetic Variants of Innate Immune Receptors and Infections After Liver Transplantation","volume":"20","author":"Sanclemente","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.155.6.3013","article-title":"Interplay Between Promoter and Structural Gene Variants Control Basal Serum Level of Mannan-Binding Protein","volume":"155","author":"Madsen","year":"1995","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1034\/j.1600-065X.2001.1800108.x","article-title":"Mannose-Binding Lectin: Targeting the Microbial World for Complement Attack and Opsonophagocytosis","volume":"180","author":"Jack","year":"2001","journal-title":"Immunol Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An Important Role for Type III Interferon (IFN-\u03bb\/IL-28) in TLR-Induced Antiviral Activity","volume":"180","author":"Ank","year":"2008","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000145989.22373.03","article-title":"Late-Onset Cytomegalovirus Disease in Liver Transplant Recipients Despite Antiviral Prophylaxis","volume":"78","author":"Limaye","year":"2004","journal-title":"Transplantation"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1086\/427506","article-title":"Late-Onset Cytomegalovirus Disease as a Significant Complication in Solid Organ Transplant Recipients Receiving Antiviral Prophylaxis: A Call to Heed the Mounting Evidence","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23460","article-title":"Prophylaxis Versus Preemptive Therapy for Cytomegalovirus Disease in High-Risk Liver Transplant Recipients","volume":"18","author":"Bodro","year":"2012","journal-title":"Liver Transplant"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3138","article-title":"Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial","volume":"323","author":"Singh","year":"2020","journal-title":"JAMA - J Am Med Assoc"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-020-0353-1","article-title":"Tutorial: A Guide to Performing Polygenic Risk Score Analyses","volume":"15","author":"Choi","year":"2020","journal-title":"Nat Protoc"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.897912\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T03:25:25Z","timestamp":1676345125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.897912\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2022.897912"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.897912","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"article-number":"897912"}}